Are future healthcare professionals adequately prepared to recognise the early signs of oral cancer? A new multicentre study reveals gaps in knowledge, awareness and reported practices among healthcare students. We explore what the findings mean for clinical recognition, timely referral and multidisciplinary education—and why knowing the warning signs may not be enough.
Can intralesional immunotherapy change how we manage oral epithelial dysplasia? An early clinical trial of nivolumab reports encouraging results in lesion reduction and histological improvement. We examine the findings, safety considerations, and the critical question: can these responses actually reduce the risk of oral cancer?
Why Does That Matter in Oral Cancer? When most of us learned molecular biology, the focus was on genes that produce proteins. Proteins regulate cellular function, control signalling pathways, and play important roles in health and disease. Naturally, they became …
A focused session exploring how mitochondrial behavior shapes disease progression in oral submucous fibrosis — from fission–fusion dynamics to their role in myofibroblast differentiation. Discover the full event details, speaker lineup, and registration options on our main Oral Pathology 360 …